<DOC>
	<DOCNO>NCT02361801</DOCNO>
	<brief_summary>Inotropic agent usually administer postoperative period cardiac surgery . In case , dobutamine administer routinely , probable occurrence myocardial dysfunction cardiopulmonary bypass low cardiac output minimal evidence alter tissue perfusion . Recent data show inotropic agent use 35-52 % cardiac surgery perioperative period . However , use inotropic agent may associate adverse event , include myocardial ischemia , elevation myocardial oxygen consumption imbalance supply consumption , tachyarrhythmias ( atrial fibrillation , sinus tachycardia , ventricular tachyarrhythmias ) , primarily due Î²1-adrenergic effect . This study non-inferiority clinical randomize study aim compare use dobutamine liberal strategy ( patient time withdrawal CPB ) restrictive strategy ( base clinical hemodynamic evidence low cardiac output syndrome associate altered tissue perfusion ) . Our primary hypothesis restrictive use dobutamine safe effective liberal one .</brief_summary>
	<brief_title>Liberal Versus Restrictive Use Dobutamine Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Patients undergo cardiac surgery coronary artery bypass graft ( CABG ) cardiopulmonary bypass ; Age equal great 18 year ; Written inform consent . Previous ventricular dysfunction ( ejection fraction lower 50 % ) Sustained supraventricular ventricular arrhythmia ; Cardiogenic shock need inotropes surgery ; Immediate need ventricular assist device intraaortic balloon CPB ; Combined procedure ; Pregnancy ; Participation another study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>cardiac surgery</keyword>
	<keyword>dobutamine</keyword>
</DOC>